PDF(1584 KB)
Clinical features of children with recurrent Kawasaki disease: a Meta analysis
LUO Gang, PAN Si-Lin, WANG Si-Bao, DU Zhan-Hui, JI Zhi-Xian
Chinese Journal of Contemporary Pediatrics ›› 2020, Vol. 22 ›› Issue (12) : 1306-1312.
PDF(1584 KB)
PDF(1584 KB)
Clinical features of children with recurrent Kawasaki disease: a Meta analysis
Objective To study the clinical features of children with recurrent Kawasaki disease (KD). Methods PubMed, Web of Science, Embase, CNKI, Wanfang Med Online, and Weipu Data were searched for case-control studies on the clinical features of initial and recurrent KD. The articles were screened according to the inclusion and exclusion criteria. RevMan 5.3 software was used to perform the Meta analysis. Effect models were selected based on the results of heterogeneity test, and then pooled OR or weighted mean difference (WMD), and their 95% CI were calculated. Results A total of 9 case-control studies were included, with 12 059 children with KD in total, among whom 206 children had recurrent KD (127 boys/61.7%; 79 girls/38.3%). The results of the Meta analysis showed that compared with the initial KD onset, the children with recurrent KD had a shorter duration of fever (WMD=-1.81, 95%CI:-2.99 to -0.64) and a lower proportion of children with swelling of the hands and feet (OR=0.46, 95%CI:0.26 to 0.80). There was no significant difference in the incidence rate of coronary artery lesions between recurrent KD and initial KD (OR=1.34, 95%CI:0.84 to 2.14). Conclusions Current evidence shows that children with recurrent KD tend to have a shorter duration of fever and a lower incidence of swelling of the hands and feet. KD recurrence is more common in boys. Current evidence does not show an increased risk of developing coronary artery lesions in children with recurrent KD.
Kawasaki disease / Meta analysis / Recurrence / Clinical feature / Child
[1] Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17):2747-2771.
[2] Bell DM, Morens DM, Holman RC, et al. Kawasaki syndrome in the United States 1976 to 1980[J]. Am J Dis Child, 1983, 137(3):211-214.
[3] 付培培, 杜忠东, 潘岳松. 2002-2010年北京儿童医院川崎病住院患儿临床分析[J]. 实用儿科临床杂志, 2012, 27(9):661-664.
[4] 王宏伟, 程佩萱. 川崎病再发10例临床分析及文献复习[J]. 中国实用儿科杂志, 2003, 18(2):96-98.
[5] 孔东明, 邓淑珍, 王瑞耕, 等. 川崎病再发22例[J]. 实用儿科临床杂志, 2012, 27(21):1668-1669.
[6] 姚晓利, 张静. 儿童再发川崎病77例临床特征回顾性分析[J]. 中国循证儿科杂志, 2013, 8(6):442-446.
[7] 刘仕成, 朴金花, 韩燕燕. 再发川崎病13例临床分析[J]. 中华临床医师杂志(电子版), 2010, 4(7):1123-1124.
[8] 邹丽霞, 龚方戚. 再发川崎病20例临床分析[J]. 中国当代儿科杂志, 2008, 10(5):617-619.
[9] 王珍全, 金佳蕙, 荣星, 等. 再发川崎病17例临床分析[J]. 浙江临床医学, 2014, 16(8):1279-1280.
[10] Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors[J]. Eur J Pediatr, 2013, 172(12):1641-1647.
[11] 王芳洁, 孙力安, 冯迎军. 川崎病再发9例[J]. 中外健康文摘, 2013(39):80-82.
[12] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan:results of the 2009-2010 nationwide survey[J]. J Epidemiol, 2012, 22(3):216-221.
[13] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999.
[14] Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease[J]. J Pediatr, 2008, 153(1):117-121.
[15] Kobayashi T, Fuse S, Sakamoto N, et al. A new Z score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma method in a pediatric population[J]. J Am Soc Echocardiogr, 2016, 29(8):794-801.e29.
[16] Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL].[2020-04-10]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
[17] Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada[J]. Pediatr Int, 2012, 54(3):383-387.
[18] Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease:USA and Japan[J]. Pediatr Int, 2015, 57(6):1116-1120.
[19] de La Harpe M, di Bernardo S, Hofer M, et al. Thirty years of Kawasaki disease:a single-center study at the University Hospital of Lausanne[J]. Front Pediatr, 2019, 7:11.
[20] Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan:results of the 2007-2008 nationwide survey[J]. J Epidemiol, 2010, 20(4):302-307.
[21] Kim GB, Park S, Eun LY, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014[J]. Pediatr Infect Dis J, 2017, 36(5):482-485.
[22] Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years[J]. Acta Paediatr, 2017, 106(5):796-800.
[23] 李菲, 周娟, 丁媛, 等. 单中心6年川崎病住院患儿早期并发冠状动脉瘤危险因素分析[J]. 中华实用儿科临床杂志, 2019, 34(9):680-683.
[24] Sharma SD, Chaturvedi K, Saini A, et al. Recurrence of coronary artery lesions after complete regression in a peculiar case of Kawasaki disease[J]. Cardiol Young, 2019, 29(5):714-716.
